TWO-YEAR EFFICACY AND SAFETY OF RAVULIZUMAB IN ADULTS AND CHILDREN WITH ATYPICAL HEMOLYTIC UREMIC SYNDROME: ANALYSIS OF TWO PHASE 3 STUDIESBradley Dixon, Alvaro Domingo Madris-Aris,Brigette Adams,David Kavanagh,Hee Gyung Kang,Jimmy Wang,Katherine Garlo,Kazuki Tanaka,Larry Greenbaum,Masayo Ogawa,Nils Heyne,Seong Heon Kim,Spero Cataland,Sung-Soo Yoon,Yoshitaka Miyakawa,Yosu Luque,Melissa Muff-LuettBlood(2022)引用 2|浏览11暂无评分摘要Background更多查看译文AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要